-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Checkpoint Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2017 to Q2 2024.
- Checkpoint Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 292 %, a 17.4% decline year-over-year.
- Checkpoint Therapeutics, Inc. annual Return On Equity for 2023 was 267 %.
- Checkpoint Therapeutics, Inc. annual Return On Equity for 2022 was -3.65K %, a 2941% decline from 2021.
- Checkpoint Therapeutics, Inc. annual Return On Equity for 2021 was -120 %, a 33.7% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)